Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05733832 · ClinicalTrials.gov registry record · NA
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
A NA study of Liver Diseases, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 4
- Study locations
NCT05733832: Recruiting NA study of Liver Diseases, sponsored by Indiana University.
NCT05733832 is a NA study of Liver Diseases that is actively recruiting participants, run by Indiana University. The registered enrollment target is 1,000 participants, below the 61,128-participant average among 33 other Liver Diseases trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05733832, a NA study of Liver Diseases, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
Patients with complications of advanced liver disease often have difficulties after hospital discharge that result in early hospital readmission. Poor outcomes for these patients during this transitional time could be improved through the use of innovative transitional care models. This proposal aims to examine the effect of a transitional care model, The Transitional Liver Clinic (TLC), in reducing hospital re-admissions, improving quality of life, and improving patient experience.
Primary Outcome
The primary outcome, 30-day hospital readmission, is publicly reported by CMS, and is the benchmark measure in the Hospital Readmissions Reduction Program. It is therefore the most appropriate primary outcome.
Conditions Studied
Interventions
- OTHER Transitional Liver Clinic (TLC)
Study Locations (4)
Illinois
- University of Chicago - Chicago
Indiana
- Indiana University Division of Gastroenterolgy and Hepatology - Indianapolis
Michigan
- University of Michigan - Ann Arbor
Pennsylvania
- Albert Einstein Healthcare Network - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT05733832 shows while recruiting
NCT05733832 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 61,128-participant average among 33 other Liver Diseases trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which Transitional Liver Clinic (TLC) is the first listed.
NCT05733832 reports a single indexed study location in Illinois, Indiana, Michigan.
Frequently Asked Questions
What is clinical trial NCT05733832 about?
NCT05733832 is a clinical study titled "A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease". Patients with complications of advanced liver disease often have difficulties after hospital discharge that result in early hospital readmission. Poor outcomes for these patients during this transitional time could be improved through the use of innovative transitional care models. This proposal aim...
What is the current status of trial NCT05733832?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2023-09-01. Estimated completion is 2028-06-30.
What conditions does trial NCT05733832 study?
This clinical trial studies the following conditions: Liver Diseases.
What interventions are being tested in trial NCT05733832?
The interventions under investigation include: Transitional Liver Clinic (TLC) (OTHER).
Who is sponsoring clinical trial NCT05733832?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05733832 being conducted?
This trial has 4 study locations across Illinois, Indiana, Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05733832's enrollment target sits among peer trials
1,000 7th of 33 higher than 26 of 33 other Liver Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
RECRUITING · NA
-
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RECRUITING · NA
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
RECRUITING · NA
-
Liver Cancer Prevention Randomized Control Trial
ACTIVE NOT RECRUITING · NA
-
Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI